Cell entry mechanisms of SARS-CoV-2

Cited by (1,003)

Items 601–700 of 1,003

1. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
   Jun-Gyu Park, Fatai S. Oladunni, Kevin Chiem, Chengjin Ye, Michael S. Piepenbrink, Thomas M. Moran, Mark R. Walter, James J. Kobie, Luis Martínez‐Sobrido · 2020 · Journal of Virological Methods
2. Kidney ACE2 expression: Implications for chronic kidney disease
   Nicholas A. Maksimowski, Vanessa R. Williams, James William Scholey · 2020 · PLoS ONE
3. Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry Inhibitors
   Yuting Li, Chan Yang, Yan Ling Wu, Jun‐Jiang Lv, Xiao Feng, Xiaofei Tian, Zhengzheng Zhou, Xiaoyan Pan, Shuwen Liu, Liwen Tian · 2021 · Journal of Natural Products
4. A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
   Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, Dianfan Li · 2021 · PLoS Pathogens
5. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2
   Susana A. Llivisaca-Contreras, Jaime Naranjo-Morán, Andrea Pino-Acosta, Luc A. C. Pieters, Wim Vanden Berghe, Patricia Manzano, Jeffrey Vargas Pérez, Fabián León-Tamaríz, Juan Manuel Cevallos‐Cevallos · 2021 · Molecules
6. Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
   Kevin G. Chen, Kyeyoon Park, Jason R. Spence · 2021 · Nature Cell Biology
7. Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages
   Hannah S. Eisfeld, Alexander Simonis, Sandra Winter, Jason Chhen, L.J. Stroh, Thomas Krey, Manuel Koch, Sebastian Julian Theobald, Jan Rybniker · 2021 · Viruses
8. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
   Daniella M. Mizurini, Eugênio Damaceno Hottz, Patrícia Torres Bozza, Robson Q. Monteiro · 2021 · Frontiers in Cardiovascular Medicine
9. Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants
   Zhen Lu Yang, Shuo Zhang, Yuping Tang, Sai Zhang, Ding-Qiao Xu, Shi‐Jun Yue, Qiling Liu · 2022 · Aging and Disease
10. Rapid detection of SARS-CoV-2: The gradual boom of lateral flow immunoassay
    Jing He, Shuying Zhu, Jiawei Zhou, Wenjie Jiang, Liliang Yin, Lan Su, Xinling Zhang, Qi Chen, Xiaoping Li · 2023 · Frontiers in Bioengineering and Biotechnology
11. Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
    Adam D. Kenney, Ashley Zani, Jeffrey Kawahara, Adrian C. Eddy, Xiao‐Liang Wang, KC Mahesh, Mijia Lu, Jeronay King Thomas, Jacob E. Kohlmeier, Mehul S. Suthar et al. · 2023 · EMBO Reports
12. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
    Mauro Giorgi, Silvia Cardarelli, Federica Ragusa, Michele Saliola, Stefano Biagioni, Giancarlo Poiana, Fabio Naro, Mara Massimi · 2020 · International Journal of Molecular Sciences
13. Clinical and molecular characterization of COVID-19 hospitalized patients
    Elisa Benetti, Annarita Giliberti, Arianna Emiliozzi, Floriana Valentino, Laura Bergantini, Chiara Fallerini, Federico Anedda, Sara Amitrano, Edoardo Conticini, Rossella Tita et al. · 2020 · PLoS ONE
14. Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting
    Kaitlin Sawatzki, Nichola J. Hill, Wendy Blay Puryear, Alexa D. Foss, Jonathon J. Stone, Jonathan A. Runstadler · 2021 · Proceedings of the National Academy of Sciences
15. Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
    Lei Peng, Yingxia Hu, Madeleine C. Mankowski, Ping Ren, Rita E. Chen, Jin Wei, Min Zhao, Tongqing Li, Therese N. Tripler, Lupeng Ye et al. · 2022 · Nature Communications
16. T cell perturbations persist for at least 6 months following hospitalization for COVID-19
    Melissa Govender, Francis R. Hopkins, Robin Göransson, Cecilia Svanberg, Esaki Muthu Shankar, Maria Hjorth, Åsa Nilsdotter‐Augustinsson, Johanna Sjöwall, Sofia N. Nyström, Marie Larsson · 2022 · Frontiers in Immunology
17. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
    Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi · 2023 · Vaccines
18. Recent Advances in Quantum Dot-Based Lateral Flow Immunoassays for the Rapid, Point-of-Care Diagnosis of COVID-19
    Seyyed Mojtaba Mousavi, Masoomeh Yari Kalashgrani, Ahmad Gholami, Navid Omidifar, Mojtaba Binazadeh, Wei‐Hung Chiang · 2023 · Biosensors
19. Global impact of proteoglycan science on human diseases
    Christopher Xie, Liliana Schaefer, Renato V. Iozzo · 2023 · iScience
20. Human coronavirus spike protein-host receptor recognition
    Lalitha Guruprasad · 2020 · Progress in Biophysics and Molecular Biology
21. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure
    Alessandra Stasi, Giuseppe Castellano, Elena Ranieri, Barbara Infante, Giovanni Stallone, Loreto Gesualdo, Giuseppe Stefano Netti · 2020 · Journal of Clinical Medicine
22. Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus
    Camila Martin Cardozo, Pierre L. Hainaut · 2021 · Current Opinion in Oncology
23. Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide
    Eileen Socher, Marcus Conrad, Lukas Heger, Friedrich P. Paulsen, Heinrich Sticht, Friederike Zunke, Philipp Arnold · 2021 · Biomedicines
24. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications
    Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Enrico Squiccimarro, Giuseppe Castellano, Loreto Gesualdo · 2021 · International Journal of Molecular Sciences
25. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus
    Yuji Kondo, Jason L. Larabee, Liang Gao, Huiping Shi, Bojing Shao, Christopher Hoover, J. Michael McDaniel, Yen‐Chun Ho, Robert Silasi‐Mansat, Stephanie A. Archer‐Hartmann et al. · 2021 · JCI Insight
26. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
    Charitha Gangadharan, Rupa Ahluwalia, Alben Sigamani · 2021 · World Journal of Diabetes
27. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants
    Linda van Oosten, Jort J. Altenburg, Cyrielle E. Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, Adrie H. Westphal, Simon Lindhoud, W. van den Berg, Daan C. Swarts et al. · 2021 · mBio
28. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
    Dibya Ghimire, Yang Han, Maolin Lu · 2022 · Viruses
29. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
    Reem Yussuf AlJindan, Abeer M. Al‐Subaie, Ahoud I. Al-Ohali, D. Thirumal Kumar, C. George Priya Doss, Balu Kamaraj · 2021 · Computers in Biology and Medicine
30. Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
    Ahmed L. Alaofi, Mudassar Shahid · 2021 · Biomolecules
31. Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing
    Özkan Fidan, Somdutt Mujwar, Mateusz Kciuk · 2022 · Molecular Diversity
32. Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
    Weihang He, Xiaoqiang Liu, Bing Hu, Dongshui Li, Luyao Chen, Yu Li, Yechao Tu, Situ Xiong, Gongxian Wang, Jun Deng et al. · 2022 · Frontiers in Cellular and Infection Microbiology
33. COVID-19: From emerging variants to vaccination
    Thilini Hemali Senevirathne, Demi Wekking, Joseph W. R. Swain, Cinzia Solinas, Pushpamali De Silva · 2023 · Cytokine & Growth Factor Reviews
34. Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silico
    Varughese Deepthi, Aswathy Sasikumar, Kochupurackal P. Mohanakumar, Usha Rajamma · 2025 · Scientific Reports
35. Nucleic acid-based therapy for coronavirus disease 2019
    Ravikant Piyush, Keshav Rajarshi, Aroni Chatterjee, Rajni Khan, Shashikant Ray · 2020 · Heliyon
36. Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications
    Yan Shan Loo, Rajendran JC Bose, Jason R. McCarthy, Intan Diana Mat Azmi, Thiagarajan Madheswaran · 2020 · Drug Discovery Today
37. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets
    Ali F. Alsulami, S.E. Thomas, Arian R. Jamasb, Christopher A. Beaudoin, Ismail Moghul, Bridget P. Bannerman, Liviu Copoiu, Sundeep Chaitanya Vedithi, Pedro Henrique Monteiro Torres, Tom L. Blundell · 2020 · Briefings in Bioinformatics
38. SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions
    Chandrika Bhattacharyya, Chitrarpita Das, Arnab Ghosh, Animesh Kumar Singh, Souvik Mukherjee, Partha Pratim Majumder, Analabha Basu, Nidhan K. Biswas · 2021 · Infection Genetics and Evolution
39. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action
    Marta De Angelis, Bruno Casciaro, A. Genovese, Diego Brancaccio, Maria Elena Marcocci, Ettore Novellino, Alfonso Carotenuto, Anna Teresa Palamara, Maria Luisa Mangoni, Lucia Nencioni · 2021 · The FASEB Journal
40. Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
    Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, Shamima Afrose, Mohasana Akter Mita, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Alomgir Hossain, Maria Meha Promi, FAHMIDA KHAN EMA et al. · 2021 · Frontiers in Molecular Biosciences
41. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
    Alex J.B. Kreutzberger, Anwesha Sanyal, Ravi Ojha, Jesse D. Pyle, Olli P. Vapalahti, Giuseppe Balistreri, Tomas L. Kirchhausen · 2021 · Journal of Virology
42. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
    Hi Eun Jung, Heung Kyu Lee · 2021 · Viruses
43. A comprehensive review on potential therapeutics interventions for COVID-19
    Heerak Chugh, Amardeep Awasthi, Yashi Agarwal, Rajesh K Gaur, Gagan Dhawan, Ramesh Chandra · 2020 · European Journal of Pharmacology
44. Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
    Suzy Huijghebaert, Levi Hoste, Guido Vanham · 2021 · European Journal of Clinical Pharmacology
45. Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design
    Timothy P. Riley, Hui‐Ting Chou, Ruozhen Hu, Krzysztof P. Bzymek, Ana R. Correia, Alexander C. Partin, Danqing Li, Danyang Gong, Zhulun Wang, Xinchao Yu et al. · 2021 · Frontiers in Immunology
46. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
    Helen Stölting, Laury Baillon, Rebecca Frise, Katie Bonner, Richard J. Hewitt, Philip L. Molyneaux, Mindy L. Gore, William Barclay, Sejal Saglani, Clare M. Lloyd · 2022 · Mucosal Immunology
47. Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
    Shibi Muralidar, Gayathri Gopal, Senthil Visaga Ambi · 2021 · Journal of Medical Virology
48. Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication
    Marek Widera, Alexander Wilhelm, Tuna Toptan, Johanna M. Raffel, Eric Kowarz, Fabian Roesmann, Finn Grözinger, Anna Lena Siemund, Vanessa Luciano, Marius Külp et al. · 2021 · Frontiers in Microbiology
49. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection
    Xin Wang, Gang Xu, Xiaoju Liu, Yang Liu, Shuye Zhang, Zheng Zhang · 2021 · Cellular and Molecular Immunology
50. Pulmonary surfactant as a versatile biomaterial to fight COVID-19
    Lore Herman, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Journal of Controlled Release
51. Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
    Iuliia A. Merkuleva, D. Shcherbakov, M. B. Borgoyakova, D. Shanshin, A. P. Rudometov, L. Karpenko, S. Belenkaya, A. A. Isaeva, V. S. Nesmeyanova, E. Kazachinskaia et al. · 2022 · Vaccines
52. Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
    Lanying Du, Yang Yang, Xiujuan Zhang, Fang Li · 2021 · Nanoscale
53. Molecular Virology of SARS-CoV-2 and Related Coronaviruses
    Yu-An Kung, Kuo-Ming Lee, Huan-Jung Chiang, Sheng‐Yu Huang, Chung-Jung Wu, Shin‐Ru Shih · 2022 · Microbiology and Molecular Biology Reviews
54. Principles of SARS-CoV-2 glycosylation
    Himanshi Chawla, Elisa Fadda, Max Crispin · 2022 · Current Opinion in Structural Biology
55. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
    Hirak Chakraborty, Surajit Bhattacharjya · 2020 · Biophysical Chemistry
56. COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis
    Ernst Emmanuel Etienne, Bharath Babu Nunna, Niladri Talukder, Yudong Wang, Eon Soo Lee · 2021 · Bioengineering
57. COVID-19 Vaccines: Current and Future Perspectives
    Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, Maria Elsa Gambuzza, Claudio Pulvirenti, Annalisa Cozza, Andrea Corsonello, Filippo Luciani, Giovanni Rezza · 2022 · Vaccines
58. Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19
    Zahra Shabani, Jialing Liu, Hua Su · 2023 · Biology
59. COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
    Carlo Contini, Elisabetta Caselli, Fernanda Martini, Martina Maritati, Elena Torreggiani, Silva Seraceni, Fortunato Vesce, Paolo Perri, Leonzio Rizzo, Mauro G. Tognon · 2020 · Microorganisms
60. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
    Yudibeth Sixto‐López, José Correa‐Basurto, Martiniano Bello, Bruno Landeros‐Rivera, José Antonio Garzón Tiznado, Sarita Montaño · 2021 · Scientific Reports
61. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
    Alessandro Ottaiano, Stefania Scala, Crescenzo D’Alterio, Anna Maria Trotta, Anna Maria Bello, Giuseppina Rea, Carmine Picone, Mariachiara Santorsola, Antonella Petrillo, Guglielmo Nasti · 2021 · Therapeutic Advances in Medical Oncology
62. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
    M. Garrett, Jared G. Galloway, Helen Chu, Hannah L. Itell, Caitlin I. Stoddard, C. Wolf, Jennifer K. Logue, Dylan McDonald, Haidyn Weight, F. Matsen et al. · 2021 · Cell
63. COVID-19: A Redox Disease—What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment
    Andrew F. Cumpstey, Anna D. Clark, Jérôme Santolini, Alan A. Jackson, Martin Feelisch · 2021 · Antioxidants and Redox Signaling
64. Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · Journal of Chemical Theory and Computation
65. COVID‐19 and the liver: A 2021 update
    C Wendy Spearman, Alessio Aghemo, Luca V. C. Valenti, Mark Wayne Sonderup · 2021 · Liver International
66. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
    Daniel J. Rawle, Thuy T. Le, Troy D. Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, Daniel Watterson, Naphak Modhiran, Jody Hobson‐Peters, Cameron Bishop et al. · 2021 · PLoS Pathogens
67. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage
    Mohsen Karami Fath, Abolfazl Jahangiri, Mahmoud Ganji, Fatemeh Sefid, Zahra Payandeh, Zahra Sadat Hashemi, Navid Pourzardosht, Anahita Hessami, Maysam Mard‐Soltani, Alireza Zakeri et al. · 2021 · Frontiers in Immunology
68. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
    María Laura Sáiz, Marta L. DeDiego, Darío López-García, Viviana Corte-Iglesias, Aroa Baragaño Raneros, Iván Astola, Víctor Asensi, Carlos López‐Larrea, Beatriz Suárez-Álvarez · 2021 · Clinical Epigenetics
69. Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies
    Witoo Dilokthornsakul, Ramanya Kosiyaporn, Rattanamanee Wuttipongwaragon, Piyameth Dilokthornsakul · 2022 · Journal of Chinese Integrative Medicine
70. Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2
    Wakana Saso, Masako Yamasaki, Shin‐ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, Nongluk Sriwilaijaroen, Osamu Kanie, Masamichi Muramatsu, Yoshimasa Takahashi et al. · 2022 · PLoS Pathogens
71. Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods
    Geetanjali Negi, Anurag Sharma, Manorama Dey, Garvita Dhanawat, Nagma Parveen · 2022 · Biophysical Reviews
72. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry
    Yeeun Kim, Guehwan Jang, Duri Lee, Nara Kim, Jeong Won Seon, Young-Hoan Kim, Changhee Lee · 2022 · Archives of Virology
73. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding
    Shahzaib Ahamad, Kanipakam Hema, Dinesh Kumar Gupta · 2020 · Journal of Biomolecular Structure and Dynamics
74. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
    Xianglei Liu, Aleksandra K. Drelich, Wei Li, Chuan Chen, Zehua Sun, Megan Shi, Cynthia Adams, John W. Mellors, Chien-Te Kent Tseng, Dimiter Stanchev Dimitrov · 2020 · Vaccine
75. Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages
    Pureum Lee, Chang-Ung Kim, Sang Hwan Seo, Doo‐Jin Kim · 2021 · Immune Network
76. ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
    Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jérôme Deval, Dinah Misner, Dorothée Bardiot, Caroline Shi-Yan Foo, Liu C et al. · 2021 · Biochemical and Biophysical Research Communications
77. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect
    Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo · 2021 · Molecules
78. Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
    Roberto Berni Canani, Marika Comegna, Lorella Paparo, Gustavo Cernera, Cristina Bruno, Caterina Strisciuglio, Immacolata Zollo, Antonietta Gerarda Gravina, Erasmo Miele, Elena Cantone et al. · 2021 · Frontiers in Pediatrics
79. Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
    Min Li, Sanpeng Li, Yixuan Huang, Haixia Chen, Songya Zhang, Zhicheng Zhang, Weigang Wu, Xiaobin Zeng, Boping Zhou, Bin Li · 2021 · Advanced Materials
80. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells
    Jinfeng Peng, Jiwei Sun, Jiajia Zhao, Xuliang Deng, Fengyuan Guo, Lili Chen · 2021 · Journal of Translational Medicine
81. Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities
    Dipankar Gupta, Ashok Kumar, Avinash Singh Mandloi, Vinayak Shenoy · 2021 · Pharmacological Research
82. Broad‐Spectrum Antiviral Peptides and Polymers
    Agnès Kuroki, Joyce Tay, Guan Huei Lee, Yi Yan Yang · 2021 · Advanced Healthcare Materials
83. Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan
    Christian Geier, András Perl · 2021 · Autoimmunity Reviews
84. A second functional furin site in the SARS-CoV-2 spike protein
    Yue Zhang, Li Zhang, Jiajing Wu, Yuanling Yu, Shuo Liu, Tao Li, Qianqian Li, Ruxia Ding, Haixin Wang, Jianhui Nie et al. · 2021 · Emerging Microbes & Infections
85. Pannexin-1 channel opening is critical for COVID-19 pathogenesis
    Ross H. Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Conover Spray, Maximiliano Rovegno, Juan Enrique Tichauer, Andréa Cottignies-Calamarte, Arielle R. Rosenberg, Calude Capron et al. · 2021 · iScience
86. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
    J. Guenthoer, M. Lilly, Tyler N. Starr, Bernadeta Dadonaite, Klaus N. Lovendahl, Jacob T. Croft, Caitlin I. Stoddard, V. Chohan, Shi-Lei Ding, Felicitas Ruiz et al. · 2023 · Proceedings of the National Academy of Sciences of the United States of America
87. SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients
    Aditya Sahai, Rohan Bhandari, Milka Koupenova, Jane E. Freedman, Mathew Godwin, Thomas M. McIntyre, Mina K. Chung, Jean‐Pierre Iskandar, Hayaan Kamran, Anu Aggarwal et al. · 2020
88. A multitask transfer learning framework for the prediction of virus-human protein–protein interactions
    Dong, Thi Ngan, Brogden, Graham, Gerold, Gisa, Khosla, Megha · 2021 · BMC Bioinformatics
89. Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research
    Andrew J. Levine, Ned C Sacktor, James T. Becker · 2020 · Journal of NeuroVirology
90. Interactive Interface for Graph-Based Analyses of Dynamic H-Bond Networks: Application to Spike Protein S
    Malte Siemers, Ana‐Nicoleta Bondar · 2021 · Journal of Chemical Information and Modeling
91. Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation
    Yikai Zhang, Shijin Sun, Chunyu Du, Kaixuan Hu, Ce Zhang, Meng Liu, Qingyu Wu, Ningzheng Dong · 2022 · Journal of Biological Chemistry
92. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation
    Qi Zhang, Weichun Tang, Eduardo Stancanelli, Eunkyung Jung, Zulfeqhar Ali Syed, Vijayakanth Pagadala, Layla F. Saidi, Catherine Z. Chen, Peng Gao, Miao Xu et al. · 2023 · Nature Communications
93. Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients
    María José Lizardo-Thiebaud, Eduardo Cervantes‐Alvarez, Nathaly Limon‐de la Rosa, Farid Tejeda‐Dominguez, Mildred Palacios-Jiménez, Osvely Méndez-Guerrero, Marco Antonio Delaye-Martínez, Fátima Rodríguez-Álvarez, Beatriz Romero-Morales, Weihui Liu et al. · 2020 · Seminars in Liver Disease
94. Engineering photonics solutions for COVID-19
    Maria Soler, Alexis Scholtz, René Zeto, Andrea M. Armani · 2020 · APL Photonics
95. Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study
    Khadijeh Ahmadi, Alireza Farasat, Mosayeb Rostamian, Behrooz Johari, Hamid Madanchi · 2021 · Journal of Biomolecular Structure and Dynamics
96. Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
    Shuai Ge, Xiangjun Wang, Yajing Hou, Yuexin Lv, Cheng Wang, Huaizhen He · 2021 · European Journal of Pharmacology
97. A comprehensive library of fluorescent constructs of SARS‐CoV‐2 proteins and their initial characterisation in different cell types
    Stéphanie Miserey‐Lenkei, Katarina Trajković, Juan Martín D’Ambrosio, Amanda Jane Patel, Alenka Čopič, Pallavi Mathur, Kristine Schauer, Bruno Goud, Véronique Albanèse, Romain Gautier et al. · 2021 · Biology of the Cell
98. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
    Murtala Bello Abubakar, Dawoud Usman, Gaber El‐Saber Batiha, Natália Alves Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Idris Muhammad, Siew Hua Gan et al. · 2021 · Frontiers in Pharmacology
99. A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions
    Ssu-Hsueh Tseng, Brandon Krishna Lam, Yu Jui Kung, John W Lin, Li Liu, Ya Chea Tsai, Louise Ferrall, Richard B. S. Roden, T.‐C. Wu, Chien‐Fu Hung · 2021 · Journal of Biomedical Science
100. Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2
     Arthur Colson, Christophe Louis Depoix, Géraldine Dessilly, Paméla Baldin, Olivier Danhaive, Corinne Hubinont, Pierre Sonveaux, Frédéric Debiève · 2021 · American Journal Of Pathology